Zhou Y, Lauschke V
Hum Genet. 2021; 141(6):1113-1136.
PMID: 34652573
PMC: 9177500.
DOI: 10.1007/s00439-021-02385-x.
Boonyawat B, Monsereenusorn C, Photia A, Lertvivatpong N, Kaewchaivijit V, Jindatanmanusan P
Appl Clin Genet. 2021; 14:341-351.
PMID: 34349542
PMC: 8326781.
DOI: 10.2147/TACG.S318912.
Abuelsoud N, Fayed H, Elkateeb E
Pharmgenomics Pers Med. 2021; 14:179-187.
PMID: 33564259
PMC: 7866922.
DOI: 10.2147/PGPM.S285033.
Fei X, Shu Q, Zhu H, Hua B, Wang S, Guo L
Front Pharmacol. 2018; 9:460.
PMID: 29867468
PMC: 5949564.
DOI: 10.3389/fphar.2018.00460.
Tantawy A, Ebeid F, Adly A, El-Ghoroury E, Mostafa M
J Genet. 2018; 96(6):905-910.
PMID: 29321348
DOI: 10.1007/s12041-017-0853-0.
Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study.
El-Rashedy F, Ragab S, Dawood A, Temraz S
Indian J Med Paediatr Oncol. 2016; 36(4):265-70.
PMID: 26811598
PMC: 4711227.
DOI: 10.4103/0971-5851.171553.
NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease.
Asada A, Nishida A, Shioya M, Imaeda H, Inatomi O, Bamba S
J Gastroenterol. 2015; 51(1):22-9.
PMID: 26590936
DOI: 10.1007/s00535-015-1142-4.
A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
Odahara S, Uchiyama K, Kubota T, Ito Z, Takami S, Kobayashi H
PLoS One. 2015; 10(9):e0137798.
PMID: 26360046
PMC: 4567281.
DOI: 10.1371/journal.pone.0137798.
Monitoring thiopurine metabolites in korean pediatric patients with inflammatory bowel disease.
Kim M, Lee S, Choe Y
Yonsei Med J. 2014; 55(5):1289-96.
PMID: 25048487
PMC: 4108814.
DOI: 10.3349/ymj.2014.55.5.1289.
New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid.
Uchiyama K, Takagi T, Iwamoto Y, Kondo N, Okayama T, Yoshida N
PLoS One. 2014; 9(4):e95080.
PMID: 24762746
PMC: 3999094.
DOI: 10.1371/journal.pone.0095080.
Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia.
Garrido C, Santizo V, Mullers P, Soriano D, Avila G, Dean M
Med Oncol. 2013; 30(1):474.
PMID: 23377985
PMC: 4545520.
DOI: 10.1007/s12032-013-0474-2.
Accuracy of genotyping using the TaqMan PCR assay for single nucleotide polymorphisms responsible for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.
Osaki R, Imaeda H, Ban H, Aomatsu T, Bamba S, Tsujikawa T
Exp Ther Med. 2012; 2(5):783-786.
PMID: 22977575
PMC: 3440725.
DOI: 10.3892/etm.2011.287.
Immunomodulators and immunosuppressants for Japanese patients with ulcerative colitis.
Bamba S, Tsujikawa T, Sasaki M, Fujiyama Y, Andoh A
ISRN Gastroenterol. 2011; 2011:194324.
PMID: 21991497
PMC: 3168385.
DOI: 10.5402/2011/194324.
The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.
Moini M, Ghaderi F, Sagheb M, Tavasolli A, Azarpira N, Darai M
Mol Biol Rep. 2011; 39(4):4581-7.
PMID: 21938428
DOI: 10.1007/s11033-011-1248-6.
Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population.
Hakooz N, Arafat T, Payne D, Ollier W, Pushpakom S, Andrews J
Eur J Clin Pharmacol. 2010; 66(10):999-1003.
PMID: 20521035
DOI: 10.1007/s00228-010-0826-1.
The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.
Ban H, Andoh A, Imaeda H, Kobori A, Bamba S, Tsujikawa T
J Gastroenterol. 2010; 45(10):1014-21.
PMID: 20393862
DOI: 10.1007/s00535-010-0248-y.
Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment.
Uchiyama K, Nakamura M, Kubota T, Yamane T, Fujise K, Tajiri H
J Gastroenterol. 2009; 44(3):197-203.
PMID: 19214663
DOI: 10.1007/s00535-008-2307-1.
Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population.
Efrati E, Adler L, Krivoy N, Sprecher E
Eur J Clin Pharmacol. 2008; 65(3):257-62.
PMID: 19048244
DOI: 10.1007/s00228-008-0590-7.
Thiopurine S-methyltransferase gene (TMPT) polymorphisms in a Mexican population of healthy individuals and leukemic patients.
Taja-Chayeb L, Vidal-Millan S, Gutierrez O, Ostrosky-Wegman P, Duenas-Gonzalez A, Candelaria M
Med Oncol. 2008; 25(1):56-62.
PMID: 18188716
DOI: 10.1007/s12032-007-9002-6.
Phenotyping and genotyping studies of thiopurine S-methyltransferase in Kazaks.
Wei H, Zhou S, Li C, Zhang J, Wu J, Huang M
Pharm Res. 2005; 22(10):1762-6.
PMID: 16180135
DOI: 10.1007/s11095-005-7095-1.